secwatch.observer — SEC 8-K summary
======================================

Issuer:     NUTRA PHARMA CORP (NPHC)
CIK:        0001119643
Form:       8-K
Filed at:   2022-08-04T23:59:59+00:00
Accession:  0001493152-22-021351
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutra Pharma appoints Marcum LLP as new independent auditor after Rotenberg merger
--------------------------------------------------------------------------------

- Rotenberg, prior auditor, combined with Marcum LLP in Feb 2022; continued as subsidiary through Q1 2022.
- On July 28, 2022, Audit Committee engaged Marcum LLP as auditor for FY 2022; Rotenberg resigned.
- Rotenberg's 2021 audit report included going concern paragraph due to lack of cash, losses, capital needs.
- No disagreements or reportable events with Rotenberg during the two most recent fiscal years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1119643/000149315222021351/0001493152-22-021351-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1119643/000149315222021351/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-021351

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer